Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Commensal bacteria essential to fight off viral infections

Healthy humans harbor an enormous and diverse group of bacteria and other bugs that live within their intestines. These microbial partners provide beneficial aid in multiple ways - from helping digest food to the development of a healthy immune system.

19 Jun 2012

iBio expands iBioModulator portfolio with allowance of patent for anthrax vaccines

iBio, Inc. today announced that the US Patent Office has allowed patent application 11/706,576 entitled "Bacillus anthracis Antigens, Vaccine Compositions, and Related Methods."

19 Jun 2012

Vicks announces OTC aid for occasional sleeplessness, ZzzQuil

The makers of VicksNyQuil announced today the newest non-habit forming, over-the-counter sleep-aid that provides relief for occasional sleeplessness. ZzzQuil - It's not for colds, it's not for pain, it's just for sleep.

18 Jun 2012

Tips to avoid becoming a mosquito meal

Summer has barely begun but it's likely many people have already encountered one of the season's most ubiquitous pests - the mosquito. As is the case with many other insects, mosquitoes have made an early emergence after a mild winter and rainy spring. The National Pest Management Association (NPMA) warns that this might be one of the worst seasons yet, so break out the repellant.

18 Jun 2012

Preventable childhood deaths can be nearly eliminated in 10 years, researchers write

"Preventable childhood deaths caused by illnesses such as pneumonia and diarrhea can be nearly eliminated in 10 years," researchers from the Johns Hopkins Bloomberg School of Public Health and the National Institutes of Health write in a new commentary featured in the June issue of the Journal of the American Medical Association," a Johns Hopkins press release reports.

16 Jun 2012

Governments, private sector partners come together at Child Survival Call to Action in Washington

The two-day Child Survival Call to Action, "a conference hosted by the government in collaboration with Ethiopia, India and UNICEF to recognize and promote efforts to curtail child mortality," began in Washington, D.C., on Thursday, the Associated Press/Washington Post reports, noting that U.S. Secretary of State Hillary Clinton and actor Ben Affleck, founder of the Eastern Congo Initiative, "were two of more than 80 governmental, civil society and business leaders slated to speak at the conference Thursday and Friday."

16 Jun 2012

Interventions aimed at preventing, treating pneumonia in children need to be expanded in developing world

"This month, USAID's flagship Maternal and Child Health Integrated Program (MCHIP) joins countries around the world in celebrating International Children's Day," Dyness Kasungami, a child health team leader for MCHIP, writes in the Huffington Post Blog, adding, "While great strides in child survival have been made in the past years, we also remember those children who do not live to see their fifth birthday -- the 7.6 million children who die of preventable causes each year."

16 Jun 2012

Risks for eczema in adults identified

Eczema is particularly common in women, and is associated with exposure to gas, dust and fumes, and other allergy-based diseases, the results of a Swedish study show.

15 Jun 2012

Better care for dual-eligible Medicare-Medicaid patients could reduce hospitalization rates

Providing better care for dual-eligible Medicare-Medicaid patients could significantly reduce hospitalization rates for this population, saving taxpayers between $625 million and $1.9 billion per year, according to a new study by researchers at RTI International and Florida Atlantic University.

15 Jun 2012

Researchers outline strategy and benchmarks to curb childhood preventable deaths

Preventable childhood deaths caused by illnesses such as pneumonia and diarrhea can be nearly eliminated in 10 years according to researchers from the Johns Hopkins Bloomberg School of Public Health and the National Institutes of Health. In a new commentary featured in the June issue of the Journal of the American Medical Association, researchers outline a strategy and benchmarks for curbing childhood preventable deaths and recommend a new common vision for a global commitment to end all preventable child deaths.

15 Jun 2012

NIH awards $9 million grant to study aging and immunity to infections

The Trudeau Institute today announced that faculty member Laura Haynes, Ph.D., was awarded a grant from the National Institutes of Health (NIH) to study how aging impacts the immune system's response to influenza infection and vaccination.

15 Jun 2012

Single protein determines persistence of viral infection

Scientists from The Scripps Research Institute have shown a single protein can make the difference between an infection clearing out of the body or persisting for life. The results also show where the defects occur in the immune system without the protein and offer the possibility that targeting this signaling pathway could be beneficial for treatment of persistent viral infections in humans.

14 Jun 2012

Updated survival data from Takeda’s brentuximab vedotin Phase II trial on HL

Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced updated survival data from a pivotal Phase II clinical trial of single-agent brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma (HL) after autologous stem cell transplant (ASCT) showing that the median overall survival has not been reached after a 26.5 month median follow-up.

14 Jun 2012

Inovio to participate at Marcum Microcap Conference, BIO International Convention

Inovio Pharmaceuticals, Inc. announced today that Dr. Niranjan Sardesai, COO, will participate on a panel of senior vaccine experts at the 2012 BIO International Convention,the largest global event for the biotechnology industry. Dr. J. Joseph Kim, President and CEO, will present an overview of the company at the Marcum Microcap Conference, which is designed for investors interested in micro-cap companies.

14 Jun 2012

Interactive website improves parental compliance with asthma controller medication use

Asthma is the most common chronic illness in adolescents and children, affecting an estimated seven million children up to the age of 17 in the United States. The burden of asthma on children is substantial: kids with asthma have a three-fold greater risk of school absence than children without asthma, and asthma is the third leading cause of hospitalization among children under the age of 15.

14 Jun 2012

Caspase-11 enzyme plays an important role in Legionella infection

New research shows that an enzyme that has long been considered relatively useless to the immune response instead has an important role in setting up immune cells to kill infection-causing bacteria.

13 Jun 2012

VaxInnate commences VAX161 Phase I trial in pandemic avian influenza

VaxInnate Corporation today announced that enrollment has commenced in a Phase I clinical trial to evaluate VAX161, its novel H5 vaccine candidate in development for the prevention of pandemic avian influenza or bird flu. VaxInnate is a biotechnology firm pioneering breakthrough technology for developing novel vaccines.

13 Jun 2012

GlobalPost reports on Cuba's medical outreach to Africa

GlobalPost reports on Cuba's medical outreach to Africa, writing, "A generation ago, Fidel Castro sent Cuban soldiers to intervene in African civil conflicts and fight the Cold War against U.S. proxies. Now, Cuba's doctors are fanning out across the continent as the island expands its role in administering medical services to some of the world's most ailing countries."

12 Jun 2012

Trudeau Institute to receive sub-contract for translational research grant from NIH

The Trudeau Institute has announced it is the recipient of a sub-contract for a translational research grant from the National Institutes of Health.

12 Jun 2012

Sucrose and menthol act independently to reduce coughing

Millions of Americans reach for their cough drops or syrup at the first sign of a cough. However, scientists are unsure if and how these popular remedies work. Now, new findings from the Monell Center suggest that sucrose and menthol, ingredients commonly regarded as flavorings in these preparations, each act independently to reduce coughing.

12 Jun 2012

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Commensal bacteria essential to fight off viral infections

iBio expands iBioModulator portfolio with allowance of patent for anthrax vaccines

Vicks announces OTC aid for occasional sleeplessness, ZzzQuil

Tips to avoid becoming a mosquito meal

Preventable childhood deaths can be nearly eliminated in 10 years, researchers write

Governments, private sector partners come together at Child Survival Call to Action in Washington

Interventions aimed at preventing, treating pneumonia in children need to be expanded in developing world

Risks for eczema in adults identified

Better care for dual-eligible Medicare-Medicaid patients could reduce hospitalization rates

Researchers outline strategy and benchmarks to curb childhood preventable deaths

NIH awards $9 million grant to study aging and immunity to infections

Single protein determines persistence of viral infection

Updated survival data from Takeda’s brentuximab vedotin Phase II trial on HL

Inovio to participate at Marcum Microcap Conference, BIO International Convention

Interactive website improves parental compliance with asthma controller medication use

Caspase-11 enzyme plays an important role in Legionella infection

VaxInnate commences VAX161 Phase I trial in pandemic avian influenza

GlobalPost reports on Cuba's medical outreach to Africa

Trudeau Institute to receive sub-contract for translational research grant from NIH

Sucrose and menthol act independently to reduce coughing

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in